(Q33858756)

29 July 2017

title

Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - case report (English)

1 reference

29 July 2017

1 reference

1 reference

Cristina Popescu

1

1 reference

29 July 2017

Victoria Arama

series ordinal

2

1 reference

29 July 2017

Smaranda Gliga

series ordinal

3

1 reference

29 July 2017

publication date

31 March 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

11

1 reference

29 July 2017

page(s)

30

1 reference

Creative Commons Attribution 2.0 Generic

29 July 2017

copyright license

start time

31 March 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Pericarditis and chronic inflammatory demyelinating polyneuropathy during therapy with pegylated interferon alfa-2a for chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079687

Adverse effects of drugs in the treatment of viral hepatitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079687

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079687

Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079687

Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079687

Side effects of alpha interferon in chronic hepatitis C.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079687

A method for estimating the probability of adverse drug reactions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079687

Effects of Interleukin-1 on Blood Pressure, Sympathetic Nerve Activity, and Pituitary Endocrine Functions in Anesthetized Rats

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079687

[Mixed type-II cryoglobulinemia associated with a chronic hepatitis C virus infection]

5 July 2018

1 reference

12 December 2020

Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy

1 reference

12 December 2020

Pericarditis after therapy with interferon-alpha for chronic hepatitis C

1 reference

12 December 2020

[Pericarditis secondary to interferon alpha in chronic hepatitis C]

1 reference

12 December 2020

Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b

1 reference

12 December 2020

[Cardiotoxic properties of interferon: aggravation of atrio-ventricular block during treatment of chronic hepatitis C with peginterferon--a case report]

1 reference

12 December 2020

Pericarditis during interferon-alpha therapy in chronic myelogenous leukemia

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-11-30

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference